Fortrea Holdings (FTRE) Operating Income (2022 - 2026)

Fortrea Holdings (FTRE) reported Operating Income of -$3.4 million for Q1 2026, up 99.35% on a YoY basis from -$1.7 million in Q1 2025, and up 75.0% quarter-over-quarter from -$13.6 million in Q4 2025.

Fortrea Holdings (FTRE) Operating Income (2022 - 2026) Analysis & Trends

Fortrea Holdings has reported Operating Income for 5 years, with the latest figure at -$3.4 million in Q1 2026.

  • For the quarter ending Q1 2026, Operating Income rose 99.35% year-over-year to -$3.4 million; the trailing twelve-month figure through Mar 2026 stood at -$355.9 million (up 44.79% YoY), and the FY2025 full-year result was -$872.6 million, down 438.97% from the prior year.
  • Operating Income for Q1 2026 stood at -$3.4 million, up from -$13.6 million in the prior quarter.
  • The five-year high for Operating Income was $71.2 million in Q2 2022, with the low at -$520.1 million in Q1 2025.
  • Historically, Operating Income has averaged -$53.2 million across 5 years, with a median of -$11.1 million in 2025.
  • Annual changes were most pronounced in 2025 — Operating Income plunged 1290.64% — and 2026, when it soared 99.35%.
  • Fortrea Holdings' Operating Income stood at $14.3 million in 2022, then plunged by 267.83% to -$24.0 million in 2023, then sank by 131.67% to -$55.6 million in 2024, then soared by 75.54% to -$13.6 million in 2025, then jumped by 75.0% to -$3.4 million in 2026.
  • The last three Operating Income figures came in at -$3.4 million (Q1 2026), -$13.6 million (Q4 2025), and -$8.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -32.68 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.97 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -19.70 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -3.82 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -15.76 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.14 Bn
9 Abivax 91.96 Bn 91.96 Bn - -65.83 Mn
10 Fortrea Holdings 1.43 Bn 1.28 Bn 123.60 Mn -3.40 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -3.40 Mn
Dec 31, 2025 -13.60 Mn
Sep 30, 2025 -8.60 Mn
Jun 30, 2025 -330.30 Mn
Mar 31, 2025 -520.10 Mn
Dec 31, 2024 -55.60 Mn
Sep 30, 2024 -18.00 Mn
Jun 30, 2024 -50.90 Mn
Mar 31, 2024 -37.40 Mn
Dec 31, 2023 -24.00 Mn
Sep 30, 2023 10.30 Mn
Jun 30, 2023 31.60 Mn
Mar 31, 2023 14.10 Mn
Dec 31, 2022 14.30 Mn
Sep 30, 2022 68.90 Mn
Jun 30, 2022 71.20 Mn